Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

2.

AI is useful in low-resource areas for triaging breast masses.

3.

Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma

4.

Alkem introduces cetuximab under the trade name Cetuxa in India.

5.

African American men see biggest survival gain from healthier lifestyles post prostate cancer diagnosis


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot